Clinical Trial Update: NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates single and multiple doses of MER511 in adults with Graves' disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• MER511

Snippet

Sponsor: Merida Biosciences | Conditions: Graves Disease | Phase 1 | Status: RECRUITING